These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2170825

  • 1. IgG antibodies to asialoGM1 are more sensitive than IgM antibodies to kill in vivo natural killer cells and prematured cytotoxic T lymphocytes of mouse spleen.
    Fujii Y, Sendo F, Kamiyama T, Naiki M.
    Microbiol Immunol; 1990; 34(6):533-42. PubMed ID: 2170825
    [Abstract] [Full Text] [Related]

  • 2. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R, Suzuki S, Ebina N, Kumagai K.
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [Abstract] [Full Text] [Related]

  • 3. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 4. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 15; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 5. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H, Yogeeswaran G, Bukowski JF, Welsh RM.
    Nat Immun Cell Growth Regul; 1985 Aug 15; 4(1):21-39. PubMed ID: 3875791
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T, Sato S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Aug 15; 77(8):825-32. PubMed ID: 3093429
    [Abstract] [Full Text] [Related]

  • 8. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 9. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 10. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA, Natuk RJ, Welsh RM.
    J Immunol; 1986 Mar 15; 136(6):2280-6. PubMed ID: 3485144
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 12. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C, Dennert G.
    J Immunol; 1988 Feb 01; 140(3):744-9. PubMed ID: 2448375
    [Abstract] [Full Text] [Related]

  • 13. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A, Nestel FP, Seemayer TA, Lapp WS.
    J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA, Hiserodt JC, Abruzzo LV, Varani J.
    Cancer Res; 1986 Jul 01; 46(7):3407-12. PubMed ID: 2939945
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 17. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H, Lachmann PJ.
    Eur J Immunol; 1975 Mar 01; 5(3):185-93. PubMed ID: 1086224
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S, Naruo K, Shiho O, Tsukamoto K.
    Immunology; 1986 Oct 01; 59(2):251-9. PubMed ID: 3490435
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
    Suttles J, Schwarting GA, Stout RD.
    J Immunol; 1986 Mar 01; 136(5):1586-91. PubMed ID: 2936802
    [Abstract] [Full Text] [Related]

  • 20. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS, Rouse BT.
    J Immunol; 1983 Jul 01; 131(1):479-84. PubMed ID: 6223080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.